Scholar Rock Holding Corp. (SRRK)
49.35
+0.19
(+0.39%)
USD |
NASDAQ |
Apr 01, 16:00
48.24
-1.11
(-2.25%)
Pre-Market: 09:22
Scholar Rock Research and Development Expense (TTM) : 206.78M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Krystal Biotech, Inc. | 55.08M |
| Stoke Therapeutics, Inc. | 136.15M |
| Zymeworks, Inc. | 137.00M |
| Amylyx Pharmaceuticals, Inc. | 89.88M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |